<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:linked-data-default="http://data-service.theglobalfund.org/api" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>47045-QRA-T-ORAS</iati-identifier>
  <reporting-org ref="47045" secondary-reporter="0" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Strengthening laboratory diagnosis of TB in the region of the Americas</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">Multicountry Americas ORAS-CONHU - Tuberculosis - Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue - ORAS CONHU.  This program has the following goals: Contribuir a mejorar la calidad del diagn&#xF3;stico de TB en las redes de laboratorio mediante el fortalecimiento de las capacidades instaladas en la regi&#xF3;n / To contribute to improving the quality of TB diagnosis through capacity strengthening of the laboratory networks in the region. The objectives of this program are: Consolidar compromisos para la sostenibilidad de los LSN y los LRN en la regi&#xF3;n / To consolidate the sustainability commitments for the SRLs and NRLs in the region.  Apoyar la adopci&#xF3;n y operacionalizaci&#xF3;n de recomendaciones internacionales de TB y el diagn&#xF3;stico de TB MDR en pol&#xED;ticas nacionales, monitorear su implementaci&#xF3;n y optimizar la utilizaci&#xF3;n de equipos de TB a nivel nacional y regional / To support the adoption and operationalization of international recommendations in relation to TB and MDR-TB in national policies, monitor their implementation and optimize the use of TB equipment at national and regional levels.  Contribuir al desarrollo, armonizaci&#xF3;n e implementaci&#xF3;n de los sistemas de informaci&#xF3;n en las redes nacionales y regionales de laboratorios de TB, con un enfoque inter-program&#xE1;tico / To contribute to the development, harmonization and implementation of information systems in national and regional TB laboratory networks, with an inter-programmatic approach</narrative>
  </description>
  <participating-org role="3" type="40">
   <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
  </participating-org>
  <participating-org role="4" type="40">
   <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
  </participating-org>
  <participating-org ref="47045" role="1" type="30">
   <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
  </participating-org>
  <other-identifier ref="516a9c03-8480-472e-bc9c-51583c78c4e2" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="QRA-T-ORAS" type="A1">
   <owner-org ref="47045">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </owner-org>
  </other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2020-01-01" type="1"></activity-date>
  <activity-date iso-date="2020-01-01" type="2"></activity-date>
  <activity-date iso-date="2023-10-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="4">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Communications</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Murad HIRJI</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Senior Digital Architect</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>murad.hirji@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="2">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Lucrecia PALACIOS</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>lucrecia.palacios@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <contact-info type="3">
   <organisation>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS Tuberculosis and Malaria</narrative>
   </organisation>
   <department>
    <narrative xml:lang="EN">Grant Management Division</narrative>
   </department>
   <person-name>
    <narrative xml:lang="EN">Lucrecia PALACIOS</narrative>
   </person-name>
   <job-title>
    <narrative xml:lang="EN">Fund Portfolio Manager</narrative>
   </job-title>
   <telephone>+41 58 791 1700</telephone>
   <email>lucrecia.palacios@theglobalfund.org</email>
   <website>https://www.theglobalfund.org</website>
   <mailing-address>
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
   </mailing-address>
  </contact-info>
  <activity-scope code="3"></activity-scope>
  <recipient-region code="QRA" percentage="100" vocabulary="99" vocabulary-uri="https://data-service.theglobalfund.org/v2.1/odata/geographicareas">
   <narrative xml:lang="EN">Multicountry Americas ORAS-CONHU</narrative>
  </recipient-region>
  <sector code="12263" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Tuberculosis</narrative>
  </sector>
  <country-budget-items vocabulary="4">
   <budget-item code="C7B597A0-B5A0-4104-8A99-BA94F1C26180" percentage="24.38" vocabulary="4">
    <description>
     <narrative xml:lang="EN">External Professional services (EPS)</narrative>
    </description>
   </budget-item>
   <budget-item code="1BDFF48D-DF9D-43D5-BCDF-56FECE799046" percentage="2.93" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Equipment (HPE)</narrative>
    </description>
   </budget-item>
   <budget-item code="B035C5CE-BA09-412B-B386-BB992AA6A20F" percentage="0.42" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Health Products - Non-Pharmaceuticals (HPNP)</narrative>
    </description>
   </budget-item>
   <budget-item code="AEEC85E4-0556-495F-8F31-584DD9FF4EF3" percentage="36.23" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Human Resources (HR)</narrative>
    </description>
   </budget-item>
   <budget-item code="400CEE75-C251-4A85-AA43-BD93DF71A408" percentage="8.74" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Indirect and Overhead Costs</narrative>
    </description>
   </budget-item>
   <budget-item code="8FF157DA-C279-44D8-8148-6161B33C9E92" percentage="0.22" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Non-health equipment (NHP)</narrative>
    </description>
   </budget-item>
   <budget-item code="DC588E6C-6B65-46A8-90D7-3ACCD004E54D" percentage="2.12" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Procurement and Supply-Chain Management costs (PSM)</narrative>
    </description>
   </budget-item>
   <budget-item code="F4B643AF-C501-4424-B4BD-74AA0DA9F006" percentage="24.95" vocabulary="4">
    <description>
     <narrative xml:lang="EN">Travel related costs (TRC)</narrative>
    </description>
   </budget-item>
  </country-budget-items>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2020-11-01"></period-start>
   <period-end iso-date="2020-12-31"></period-end>
   <value currency="USD" value-date="2020-11-01">175377</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-01-01"></period-start>
   <period-end iso-date="2021-03-31"></period-end>
   <value currency="USD" value-date="2020-11-01">175748</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-04-01"></period-start>
   <period-end iso-date="2021-06-30"></period-end>
   <value currency="USD" value-date="2020-11-01">366179</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-07-01"></period-start>
   <period-end iso-date="2021-09-30"></period-end>
   <value currency="USD" value-date="2020-11-01">454776</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2021-10-01"></period-start>
   <period-end iso-date="2021-12-31"></period-end>
   <value currency="USD" value-date="2020-11-01">293018</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-01-01"></period-start>
   <period-end iso-date="2022-03-31"></period-end>
   <value currency="USD" value-date="2020-11-01">331705</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-04-01"></period-start>
   <period-end iso-date="2022-06-30"></period-end>
   <value currency="USD" value-date="2020-11-01">475630</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-07-01"></period-start>
   <period-end iso-date="2022-09-30"></period-end>
   <value currency="USD" value-date="2020-11-01">232076</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2022-10-01"></period-start>
   <period-end iso-date="2022-12-31"></period-end>
   <value currency="USD" value-date="2020-11-01">311741</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-01-01"></period-start>
   <period-end iso-date="2023-03-31"></period-end>
   <value currency="USD" value-date="2020-11-01">327627</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-04-01"></period-start>
   <period-end iso-date="2023-06-30"></period-end>
   <value currency="USD" value-date="2020-11-01">548613</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-07-01"></period-start>
   <period-end iso-date="2023-09-30"></period-end>
   <value currency="USD" value-date="2020-11-01">251175</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2023-10-01"></period-start>
   <period-end iso-date="2023-10-31"></period-end>
   <value currency="USD" value-date="2020-11-01">56337</value>
  </budget>
  <capital-spend percentage="2.93"></capital-spend>
  <transaction ref="df210162-44b0-4692-bd7f-b6876e22f39b">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2016-12-20"></transaction-date>
   <value currency="USD" value-date="2016-12-20">3430385</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0be355ec-bb83-4d9f-8da6-cd8cf67ea9cc">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-01-12"></transaction-date>
   <value currency="USD" value-date="2017-01-12">-1263749</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="778bd286-a740-4d1b-acb3-4be02e1e254a">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-01-31"></transaction-date>
   <value currency="USD" value-date="2017-01-31">-2166636</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4d6da4fc-dc6e-49d6-9d66-242c0548a1ee">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-01-31"></transaction-date>
   <value currency="USD" value-date="2017-01-31">3430385</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="7cd51e7e-63b7-401e-bda8-3ef296a679a7">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-08-13"></transaction-date>
   <value currency="USD" value-date="2018-08-13">1761979.01</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="fead4552-0ddb-4ce1-a7b5-ea4a81f35afa">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-05-15"></transaction-date>
   <value currency="USD" value-date="2019-05-15">413352.21</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="76b2a441-6333-4300-bfbc-43f72e8d9e50">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2019-11-12"></transaction-date>
   <value currency="USD" value-date="2019-11-12">504283.78</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="41d920d0-67f9-4b0a-b29d-af875ecbd644">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2020-12-03"></transaction-date>
   <value currency="USD" value-date="2020-12-03">1637076.85</value>
   <description>
    <narrative xml:lang="EN">Global Fund Commitment to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="59179416-8b6f-4607-8e5f-257a61b0550f">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2016-12-21"></transaction-date>
   <value currency="USD" value-date="2016-12-21">1263749</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="5a63d8e6-caca-41bd-bfb6-0dd3e819f617">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-02-02"></transaction-date>
   <value currency="USD" value-date="2017-02-02">1263749</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="733c8323-83d7-4cb9-8b3a-4a4e8384bc11">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-03-31"></transaction-date>
   <value currency="USD" value-date="2017-03-31">281167</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="f39a5e8c-842b-423a-859e-0c186301f4ce">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-06-28"></transaction-date>
   <value currency="USD" value-date="2017-06-28">506924</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="49c49ed5-0f1c-46ee-93fe-c3e0930f34e7">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2017-07-20"></transaction-date>
   <value currency="USD" value-date="2017-07-20">214152</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="1d21b6cc-2b32-403d-aaa5-168a389169f0">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-01-09"></transaction-date>
   <value currency="USD" value-date="2018-01-09">1009985</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="1c6ecf9a-f275-420b-bad4-a75e8ce938fa">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-03-27"></transaction-date>
   <value currency="USD" value-date="2018-03-27">154408</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="4b7f9922-a5fa-45ba-85d0-56939cf74426">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-08-14"></transaction-date>
   <value currency="USD" value-date="2018-08-14">475071.61</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="27657dce-ee60-4b1d-9872-6eb4979a6be6">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-10-04"></transaction-date>
   <value currency="USD" value-date="2018-10-04">155298.4</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="06fad863-e265-420a-afed-5b6491b28eea">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-01-03"></transaction-date>
   <value currency="USD" value-date="2019-01-03">915189.17</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="6f179d68-9da4-474f-a9fd-bba0c748ca3c">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-04-02"></transaction-date>
   <value currency="USD" value-date="2019-04-02">216419.83</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="265fdf90-f927-42cc-91bb-03e0d6b26ae7">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-06-14"></transaction-date>
   <value currency="USD" value-date="2019-06-14">106894.62</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="0e1b3d2c-d79a-4c78-a542-97b36bfa8bcc">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-09-19"></transaction-date>
   <value currency="USD" value-date="2019-09-19">306457.59</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="1550647f-3dae-42d4-9440-2297f3e8a635">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-11-14"></transaction-date>
   <value currency="USD" value-date="2019-11-14">504283.78</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="bf478c51-296d-4909-a0d1-5720b0d2b446">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-12-09"></transaction-date>
   <value currency="USD" value-date="2020-12-09">1305372.36</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">Organismo Andino de Salud - Convenio Hip&#xF3;lito Unanue</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <transaction ref="fab72c4d-a80b-4ce6-a18a-7564c5015c24">
   <transaction-type code="7"></transaction-type>
   <transaction-date iso-date="2017-01-01"></transaction-date>
   <value currency="USD" value-date="2017-01-01">-1263749</value>
   <description>
    <narrative xml:lang="EN">Global Fund disbursement to QRA-T-ORAS.</narrative>
   </description>
   <receiver-org type="40">
    <narrative xml:lang="EN">The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
   </receiver-org>
   <aid-type code="C01" vocabulary="1"></aid-type>
   <tied-status code="5"></tied-status>
  </transaction>
  <result aggregation-status="0" type="1">
   <title>
    <narrative xml:lang="EN">Coverage / Output indicator for QRA-T-ORAS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">M &amp; E-Other1: Number of countries that adopt the mechanism for monitoring laboratory indicators</narrative>
    </title>
    <baseline year="2020">
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 17 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of National Reference Laboratories accredited according to ISO15189 standard or achieving at least 4 stars towards accreditation</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 3 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">HSG-Other 1: Number of SRLs that meet sustainability commitments</narrative>
    </title>
    <baseline year="2019">
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 3 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB-other 1. Number of supranational laboratories (SRL) of TB that meet the six components defined in the terms of reference of SRL established by the Global Laboratory Initiative (GLI) of the Stop TB Partnership</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Numerator: 0 Denominator: 6 Percentage: 0.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB- other 3: Percentage of NRL with quality control and external evaluation of drug sensitivity tests (DST) of first-line drugs (INH and RFP) with WHO internationally accepted criteria for each of the anti-TB drugs evaluated.</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Numerator: 10 Denominator: 20 Percentage: 50.00</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Percentage of new and relapse TB patients tested using WHO recommended rapid tests at the time of diagnosis</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 13460 Denominator: 138207 Percentage: 9.74</narrative>
     </comment>
    </baseline>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB-other 2: Percentage of national laboratory networks (NLN) for TB that comply with standardized regional criteria for quality assurance of bacilloscopy.</narrative>
    </title>
    <baseline year="2015">
     <comment>
      <narrative xml:lang="EN">Numerator: 2 Denominator: 20 Percentage: 10.00</narrative>
     </comment>
    </baseline>
   </indicator>
  </result>
  <result aggregation-status="0" type="3">
   <title>
    <narrative xml:lang="EN">Impact indicator for QRA-T-ORAS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB incidence rate per 100,000 population</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 44.4</narrative>
     </comment>
    </baseline>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Text: 38.4</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 32.5</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 30.33173</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 31.4</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 31.30183</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 30.5</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 42.64</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-10-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 41.76</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
  <result aggregation-status="0" type="2">
   <title>
    <narrative xml:lang="EN">Outcome indicator for QRA-T-ORAS</narrative>
   </title>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Case notification rate of all forms of TB per 100,000 population - bacteriologically confirmed plus clinically diagnosed, new and relapse cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 34.8</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 36.2</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-10-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 36.9</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">Notification of RR-TB and/or MDR-TB cases &#x2013; Percentage of notified cases of bacteriologically confirmed, drug resistant RR-TB and/or MDR-TB as a proportion of all estimated RR-TB and/or MDR-TB cases</narrative>
    </title>
    <baseline year="2018">
     <comment>
      <narrative xml:lang="EN">Numerator: 4791 Denominator: 11000 Percentage: 43.55</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2022-01-01"></period-start>
     <period-end iso-date="2022-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 6110 Denominator: 11000 Percentage: 55.55</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
    <period>
     <period-start iso-date="2023-01-01"></period-start>
     <period-end iso-date="2023-10-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Numerator: 6660 Denominator: 11000 Percentage: 60.55</narrative>
       <narrative xml:lang="EN">Target for: 2022</narrative>
      </comment>
     </target>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB O-Other-2: Percentage of cases of TB with rifampicin sensitivity tests conducted via conventional methods, or quick molecular tests.</narrative>
    </title>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Text: 30.00%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 36.00</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Numerator: 43326 Denominator: 131073 Percentage: 33.05</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 45.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 39.04</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 60.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 0.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
   <indicator aggregation-status="0" measure="5">
    <title>
     <narrative xml:lang="EN">TB O-Other 1: Rate of detection of cases of tuberculosis.</narrative>
    </title>
    <baseline year="2014">
     <comment>
      <narrative xml:lang="EN">Text: 75.00%</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 81.25</narrative>
       <narrative xml:lang="EN">Target for: 2017</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2019-01-01"></period-start>
     <period-end iso-date="2019-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 81.25</narrative>
       <narrative xml:lang="EN">Target for: 2018</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 80.00</narrative>
       <narrative xml:lang="EN">Target for: 2019</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 85.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="EN">Percentage: 0.00</narrative>
       <narrative xml:lang="EN">Target for: 2020</narrative>
      </comment>
     </actual>
    </period>
    <period>
     <period-start iso-date="2020-01-01"></period-start>
     <period-end iso-date="2020-09-30"></period-end>
     <target>
      <comment>
       <narrative xml:lang="EN">Percentage: 90.00</narrative>
       <narrative xml:lang="EN">Target for: 2021</narrative>
      </comment>
     </target>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
